AlphaGrep UK Ltd Purchases 12,979 Shares of Centene Corporation $CNC

AlphaGrep UK Ltd grew its holdings in Centene Corporation (NYSE:CNC – Free Report) by 193.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,689 shares of the company’s stock after purchasing an additional 12,979 shares during the quarter. Centene comprises approximately 0.4% of AlphaGrep UK Ltd’s portfolio, making the stock its 17th largest holding. AlphaGrep UK Ltd’s holdings in Centene were worth $1,223,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new position in Centene in the 2nd quarter valued at about $2,660,422,000. Wellington Management Group LLP boosted its position in shares of Centene by 423.0% during the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock worth $853,805,000 after buying an additional 10,757,914 shares during the period. Bank of America Corp DE acquired a new stake in shares of Centene in the second quarter valued at $285,713,000. Deutsche Bank AG acquired a new stake in shares of Centene in the second quarter valued at $257,279,000. Finally, Legal & General Group Plc purchased a new stake in shares of Centene in the 2nd quarter valued at $244,463,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Centene

In other news, General Counsel Christopher Koster sold 56,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total value of $3,779,850.00. Following the completion of the sale, the general counsel directly owned 248,854 shares in the company, valued at approximately $16,648,332.60. The trade was a 18.50% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.37% of the company’s stock.

Centene Stock Down 2.7%

CNC opened at $63.81 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.16. Centene Corporation has a 1 year low of $31.63 and a 1 year high of $78.08. The company has a market cap of $31.59 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 0.37 and a beta of 1.07. The firm has a 50 day moving average price of $67.41 and a 200 day moving average price of $57.16.

Centene (NYSE:CNC – Get Free Report) last announced its earnings results on Tuesday, October 27th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.10 by $0.48. The business had revenue of $50.65 billion for the quarter, compared to the consensus estimate of $47.12 billion. Centene had a return on equity of 12.15% and a net margin of 0.72%. The company’s revenue was up 1.9% on a year-over-year basis. During the same period last year, the business posted $0.50 EPS. Sell-side analysts expect that Centene Corporation will post 5.27 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. HC Wainwright reaffirmed a “buy” rating on shares of Centene in a research note on Friday, September 11th. Wall Street Zen downgraded Centene from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 31st. JPMorgan Chase & Co. set a $90.00 price target on shares of Centene in a research note on Tuesday. Robert W. Baird increased their target price on shares of Centene from $66.00 to $71.00 and gave the company a “neutral” rating in a report on Wednesday, October 28th. Finally, Truist Financial restated a “buy” rating and issued a $82.00 price target (up from $80.00) on shares of Centene in a research report on Monday, November 2nd. Nine investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Centene has an average rating of “Hold” and a consensus price target of $75.20.

Read Our Latest Report on Centene

Centene Profile

(Free Report)

Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.

Featured Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.